Welcome to our dedicated page for Cencora SEC filings (Ticker: COR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cencora, Inc. filings document material events for a NYSE-listed pharmaceutical distribution and healthcare solutions company. Recent 8-K disclosures furnish quarterly operating results, Regulation FD information, executive officer transition details, annual meeting voting results and entries into material definitive agreements.
The company’s regulatory record also covers capital-structure matters, including common stock and listed senior notes, registered public debt offerings and the terms of multiple senior note maturities. Governance filings describe director elections and other shareholder voting matters, while material-event reports connect financing activity and completed acquisitions to the company’s operating and financial disclosures.
NALLY DENNIS M reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. reported that director Dennis M. Nally received a grant of 113 shares of common stock on July 31, 2026 at $311.34 per share, issued in lieu of a $35,000 quarterly cash retainer under the Non-Employee Director Compensation Program. After this award, he directly holds 13,188 shares.
Cooper Ellen reported acquisition or exercise transactions in this Form 4 filing.
Cencora director Ellen Cooper received a grant of 97 restricted stock units on July 31, 2026, in lieu of a $30,000 quarterly cash retainer under the Non-Employee Director Compensation Program. The award equates to $311.34 per share, bringing her direct holdings to 893 shares, with receipt deferred until she leaves the board.
Tyler Lauren M reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. reported that director Lauren M Tyler received a grant of 97 restricted stock units representing common stock on 2026-07-31 at a reference price of $311.34 per share. The award was granted in lieu of a $30,000 quarterly cash retainer under the Non-Employee Director Compensation Program, with receipt of shares deferred until cessation of service. Following the grant, Tyler directly holds 4,456 shares of common stock.
Cencora, Inc. Executive Vice President Silvana Battaglia acquired 58.2040 shares of common stock on 2026-06-30 at $240.5330 per share through the company’s Employee Stock Purchase Plan, as described under Rule 16b-3(c) and 16b-3(d). Following this compensation-related acquisition, she directly holds 23,624.0120 common shares.
Cencora, Inc. Executive Vice President Elizabeth S. Campbell acquired additional common stock through the company’s Employee Stock Purchase Plan. She obtained 49.889 shares of common stock at a price of $240.533 per share in this routine, compensation-related transaction. Following the purchase, she directly holds 30,755.556 shares of Cencora common stock.
Boratto Eva C reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. reported that Chief Financial Officer Eva C. Boratto received a grant of 21,304 Restricted Stock Units. These RSUs were granted for no cash consideration and will vest in three equal annual installments on June 29, 2027, June 29, 2028, and June 29, 2029. Following this award, she holds 21,304 RSUs directly.
Cencora, Inc. Chief Financial Officer Eva C. Boratto filed an initial Form 3 reporting a small ownership position in the company’s common stock. She reports 1 share held directly and 2 shares held indirectly through a trust for her spouse and children, with beneficial ownership disclaimed except for any pecuniary interest.
Cencora, Inc. director Lauren M. Tyler reported an open-market purchase of 550 shares of Common Stock at $270.23 per share. After this buy, Tyler directly holds 4,359 Cencora shares, indicating a modest increase in personal ownership.
Cencora, Inc. director Dermot Mark Durcan reported an open-market purchase of company stock. On June 18, 2026, he bought 4,000 shares of Cencora common stock at $274.19 per share. After this transaction, he directly holds 31,767 common shares of the company.
Cencora, Inc. announced a planned leadership transition in its human resources organization. Executive Vice President and Chief Human Resources Officer Silvana Battaglia will retire from her role effective July 12, 2026, after a seven-year tenure, and continue as an advisor through the end of 2026. The company stated her decision was not due to any disagreement regarding operations, policies, or practices.
Samantha (Sam) Hammock will join Cencora as Executive Vice President and Chief Human Resources Officer effective July 13, 2026, reporting to CEO Bob Mauch and serving on the enterprise leadership team. She previously held senior HR roles at Verizon Communications and American Express. The press release highlights Cencora’s scale, including more than 51,000 team members, over $300 billion in annual revenue, and Fortune 500 and Global 500 rankings, underscoring the strategic importance of the CHRO role.